Answers are grounded in this paper and cite their sources.
The risk of complications associated with transvenous ICDs make the subcutaneous implantable cardiac defibrillator (S-ICD) a valuable alternative in patients with adult congenital heart disease (ACHD). However, higher S-ICD ineligibility and higher inappropriate shock rates-mostly caused by T wave oversensing (TWO)- are observed in this population. We report a novel application of deep learning methods to screen patients for S-ICD eligibility over a longer period than conventional screening.
No takes yet. Share an insight, caveat, or question.
ElRefai et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: